Patent · US Active

Amplification with primers of limited nucleotide composition

US11091799B2 · kind B2 · utility

1Cited by

0References

44Claims

0Family size

Assignee

ATILA BIOSYSTEMS INCORPORATED · US

Inventors

Youxiang Wang · Palo Alto, US
Zhijie Yang · Beijing, CN
Xin Chen · Shanghai, CN

Key dates

Filing date	Apr 22, 2016
Grant date	Aug 17, 2021
Priority date	—
Expiry date	Jul 18, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Q2565/107
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

The invention provides methods of amplification from a single primer or a pair of forward and reverse primers of limited nucleotide composition. Limited nucleotide composition means that the primers are underrepresented in at least one nucleotide type. Such primers have much reduced capacity to prime from each other or to extend initiated by mispriming from other than at their intended primer binding sites in a target nucleic acid.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.